BALTIMORE, MD—July 29, 2014—Med-IQ, an award winning ACCME-accredited provider of continuing medical education (CME), invites oncologists and pathologists to join expert faculty for the interactive Webcast, Individualizing Treatment in NSCLC: Expert Perspectives on the Potential of the MET Pathway, and to read the CME publication, Advancing Toward Personalized Medicine in NSCLC: Exploring the Promise of the MET Pathway.

As evidence on key biomarkers and novel targeted therapies for non–small cell lung cancer (NSCLC) rapidly increases, the role of MET signaling must be explored and properly applied to improve patient outcomes. The webcast and publication offer clinicians an opportunity to review the role of MET signaling in NSCLC and provide strategies for identifying patients who may benefit from emerging MET directed therapies. 

“Oncologists and pathologists need to stay ahead of the rapidly mounting data for the standard of care in NSCLC as it moves closer to personalized medicine tailored to the molecular profile of individual tumors,” said Corey J. Langer MD, FACP, director of Thoracic Oncology at the Abramson Cancer Center in Philadelphia, PA.  “These CME activities offer first- line treatment insight on the potential influence of MET expression on NSCLC that can be incorporated in day-to-day practice.”

FACULTY

		Fred R. Hirsch, MD, PhD (Co-Chair) Professor of Medicine and Pathology School of Medicine Division of Medical Oncology University of Colorado Denver Aurora, CO
		Corey J. Langer, MD, FACP (Co-Chair) Director of Thoracic Oncology Abramson Cancer Center Professor of Medicine University of Pennsylvania Philadelphia, PA

To view the Webcast, visit www.med-iq.com/a765. To access the publication, visit
www.med-iq.com/a764. For more information, please call (toll-free) 866 858 7434 or e-mail
info@med-iq.com.

These activities are approved for AMA PRA Category 1 Credit™ and are supported by educational grants from Genentech.

About Med-IQ

Med-IQ, America's most respected provider of continuing medical education (CME), inspires healthcare professionals through award-winning activities that deliver sophisticated outcomes-based educational designs with measurable results in professional competence and performance. Med-IQ is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the California Board of Registered Nursing (CBRN), and the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing medical education to physicians, nurses, and pharmacists, respectively.

As a leader in the CME industry, Med-IQ has delivered 32 performance improvement (PI) and quality improvement (QI) initiatives that make use of systems-based training such as Crew Resource Management to improve team performance and patient outcomes. These initiatives have achieved improvements in healthcare provider performance, quality of care, and patient outcomes. Med-IQ's work in performance and quality education and training has been published 27 times in peer-reviewed journals, and the company has been recognized by the Alliance for Continuing Education in the Health Professions for our excellence in CE research (William Campbell Felch Award 2013, 2011), educational collaborations (2013), outstanding CME outcomes assessment (2012), and exceptional leadership (Leadership Award 2013, President’s Award 2012). To learn more about Med-IQ, visit www.Med-IQ.com, like us on Facebook, follow us on Twitter, and connect with us on LinkedIn.


For more information, contact:

Amy Caswell
Senior Audience Development Manager
Med-IQ
866 858 7434
info@med-iq.com